• Home
• Products
  • UV Phototherapy
  • Derma 308
  • MED/MPD Tester
• Order
• FAQ
  • UV Phototherapy
  • Viedo
  • Instruction
  • Real stories
• Membership
• Contact
•  
• KERNEL
  • KERNEL Website
  • Colposcope
  • Photodynamic therapy
  • Patient monitor

Survey of phototherapy practice by dermatologists in Australia.

Huynh NT1, Sullivan JR, Commens CA.

Author information

Abstract

A postal survey was sent to all dermatologists in Australia to determine current phototherapy practices. 

Questionnaires were returned by 158 (57%) of 277 dermatologists, of whom 112 (71%) provided phototherapy. Large 

variations existed in attitudes and practice, including indications, contraindications, dosage schedules, equipment 

maintenance, response to adverse events, and follow-up arrangements. Cumulative ultraviolet (UV) doses for psoralen 

and UVA (PUVA) were not calculated by 21%, while 30% did not calculate cumulative doses for UVB. Written informed 

consent was not obtained by 32%. Phototherapist dermatologists reported 25 patients developing melanoma following 

PUVA. Only 30% of Australian dermatologists organize regular follow up of patients after phototherapy. Australians 

have the highest rates of melanoma and non-melanoma skin cancers in the world, because of their ancestry and high 

solar exposure. This makes it inappropriate for Australian dermatologists to rely entirely on foreign safety data when 

assessing the risks and benefits of phototherapy in Australian patients. There is a need for standardized Australian 

guidelines that can be prospectively assessed to ensure phototherapy is used to maximize efficacy and minimize risks 

in Australian patients, given their unique ancestral mix and outdoor lifestyle.

www.kerneluvb.com----The leader manufacturer of UVB Phototherapy.